Lisa Gill
Stock Analyst at JP Morgan
(2.36)
# 2,519
Out of 4,944 analysts
139
Total ratings
41.76%
Success rate
-0.05%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $418 → $310 | $261.57 | +18.52% | 9 | Aug 6, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $472 → $384 | $292.48 | +31.29% | 5 | Jul 22, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $20.71 | +54.51% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $178.68 | +6.34% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $22.40 | +33.93% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $28.54 | +43.66% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $14.64 | +16.12% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $274.94 | -6.89% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $65.51 | +23.65% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $146.30 | -0.89% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $289.15 | +4.10% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $11.19 | +60.86% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.62 | +38.12% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $22.98 | +21.85% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.87 | +26.37% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $6.87 | +31.00% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $5.47 | +229.07% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $659.01 | +0.30% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $280.47 | +56.17% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $12.47 | +44.35% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $157.31 | +151.10% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $269.31 | -9.77% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $175.21 | +6.16% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $170.48 | -17.88% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $390.31 | -14.94% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $3.50 | +185.71% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.89 | +909.53% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $7.24 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $4.66 | +71.67% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $67.52 | +22.93% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $26.17 | +274.47% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $24.02 | - | 4 | Dec 19, 2017 |
UnitedHealth Group
Aug 6, 2025
Maintains: Overweight
Price Target: $418 → $310
Current: $261.57
Upside: +18.52%
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $292.48
Upside: +31.29%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $20.71
Upside: +54.51%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $178.68
Upside: +6.34%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $22.40
Upside: +33.93%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $28.54
Upside: +43.66%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $14.64
Upside: +16.12%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $274.94
Upside: -6.89%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $65.51
Upside: +23.65%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $146.30
Upside: -0.89%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $289.15
Upside: +4.10%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $11.19
Upside: +60.86%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.62
Upside: +38.12%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $22.98
Upside: +21.85%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.87
Upside: +26.37%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $6.87
Upside: +31.00%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $5.47
Upside: +229.07%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $659.01
Upside: +0.30%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $280.47
Upside: +56.17%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $12.47
Upside: +44.35%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $157.31
Upside: +151.10%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $269.31
Upside: -9.77%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $175.21
Upside: +6.16%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $170.48
Upside: -17.88%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $390.31
Upside: -14.94%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $3.50
Upside: +185.71%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.89
Upside: +909.53%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $7.24
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $4.66
Upside: +71.67%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $67.52
Upside: +22.93%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $26.17
Upside: +274.47%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $24.02
Upside: -